The University of Minnesota's Clinical and Translational Science Institute (CTSI) has received a $42.6 million grant through the National Institutes of Health (NIH)-funded Clinical and Translational Science Award (CTSA) program. CTSI, a Consortium member, will use the funding to train and support researchers striving to make important discoveries that will improve Minnesotans’ health. The five-year award is effective March 30, 2018 through February 28, 2023 and is one of the University’s largest federal research grants; this is the second time CTSI has received this prestigious recognition. VP for Research Allen Levine notes, "CTSI has provided important clinical and translational research support across the University, including . . . for six technologies that have led to startup ventures in areas like microbiome analysis and cancer drug delivery." New to this grant is a mentored career development component that will allow trainees to develop the skills to translate research discoveries into clinical practice.